Now where is that Viraleze, page-44

First 44 Last

Share
Profile

Follow
Starlink

1,023 Posts.

192

09/08/24

11:19

Post #: 75139219
Share

Originally posted by Teddyward: ↑

You are full of it. Also in regards to Heparin and other existing pharmaceuticals please look at the decades of knowledge and trials showing its interactions and how it can't or can't be absorbed etc. HC posters have in general been mislead by massively optimistic posters who clearly have chosen not to understand the process and system. Doesn't mean it won't succeed in some aspects in time with correct data .

As for your reference to other poster - Starts with a msiquote and then heads down an incorrect path and onto the usual conspiracy. "Clear evidence" - What a load of bull!

Please go and read TGA information and also go and learn about the other products and check the timeline of what decisions have been made historically in regards to Astodrimer sodium and Vivagel- big hint - poisons schedule - FDA package etc etc, insuffecient or incorrect data package, nil or delayed slow enrollment trials , legal challenges etc etc along with catagory change

Please go back to original source documents and real factual information not what has been written by "promoters " on HC and you will get a clearer picture of possible different choices and pathways SPL management could have made with possibly different outcomes. It is not always conspiracy . Read the last quarterly without rose coloured glasses on and recent announcements and it may become clearer IMO . SPL has chosen words carefully IMO rather than clearly come 100% clean in regards to previous CEO and program.

Don't feel vindicated if Viraleze ever gets through TGA as it is just a process

Expand

wow the advocate of reading ✔️between✔️ the lines not the actual lines. Put in your own assumptions in that white space

SPL Price at posting: 9.4¢ Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

ASX Market Update: Index pulls back from record highs | October 16, 2024

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

BM8

Battery Age Minerals gets set to capitalise on critical mineral demand

JBY

James Bay latest lithium player to pivot to other metals amidst lithium slump

PME

Pro Medicus snaffles 5-year contract extension worth $32M for RIS technology

There are more pages in this discussion • 51 more messages in this thread...

First 44 Last

Add SPL (ASX) to my watchlist

(20min delay)
Last 9.5¢		Change 0.000(0.00%)		Mkt cap ! $39.64M

Open	High	Low	Value	Volume
9.5¢	9.5¢	9.5¢	$647	6.815K

Buyers (Bids)

No.	Vol.	Price($)
1	9999	9.5¢

Sellers (Offers)

Price($)	Vol.	No.
9.8¢	159206	3

View Market Depth

No.	Vol.	Price($)
1	9999	0.095
3	160000	0.094
2	9659	0.093
2	217706	0.092
5	98353	0.090

Price($)	Vol.	No.
0.098	159206	3
0.100	49000	3
0.105	197076	6
0.110	146286	7
0.115	103400	3

Last trade - 16.10pm 16/10/2024 (20 minute delay)

SPL (ASX) Chart

Now where is that Viraleze, page-44

ASX Market Update: Index pulls back from record highs | October 16, 2024

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Battery Age Minerals gets set to capitalise on critical mineral demand

James Bay latest lithium player to pivot to other metals amidst lithium slump

Pro Medicus snaffles 5-year contract extension worth $32M for RIS technology

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Now where is that Viraleze, page-44

Top Stories

ASX Market Update: Index pulls back from record highs | October 16, 2024

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Battery Age Minerals gets set to capitalise on critical mineral demand

James Bay latest lithium player to pivot to other metals amidst lithium slump

Pro Medicus snaffles 5-year contract extension worth $32M for RIS technology

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News